PTSM: Pharmaceutical Technology Sourcing and Management
Agilent Technologies and Thermo Fisher Scientific exchange instrument control drivers and software support.
Agilent Technologies and Thermo Fisher Scientific announced an agreement on Nov. 5, 2015 to exchange instrument controls to improve the productivity and user experience of customers using the companies software and instruments.
Under this agreement, the companies will exchange instrument-control driver documentation and software for liquid chromatographs, gas chromatographs, capillary electrophoresis, and ion chromatographs. The companies will also provide technical assistance to each other’s software development groups, for control of Agilent instruments in the Thermo Scientific Chromeleon software, and Thermo Scientific instruments in the Agilent OpenLAB CDS software.
The agreement also defines terms for licensing and redistribution of instrument control software, as well as formal escalation mechanisms to jointly drive technical issue resolution for their mutual customers.
The instrument control exchange agreement reflects the increasing importance of manufacturer collaboration to achieve interoperability and standardization of multivendor instrument control, so that analytical laboratories can increase productivity while minimizing technical and regulatory risks and validation costs, according to a press statement.
Source: Agilent Technologies
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.